Trial Profile
A Randomized Phase 4 Study Comparing 2 Intravenous Temsirolimus (Temsr) Regimens In Subjects With Relapsed, Refractory Mantle Cell Lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2021
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Desipramine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors Pfizer
- 19 Jul 2018 Status changed from active, no longer recruiting to completed.
- 11 Apr 2017 Planned End Date changed from 1 Oct 2017 to 15 Jun 2018.
- 11 Apr 2017 Status changed from recruiting to active, no longer recruiting.